ADA Scientific Sessions 2026 Abstract·6 JunEfficacy and Safety of Extended-Interval PG-102, a GLP-1/GLP-2 Bispecific Agonist, in Adults with Type 2 DiabetesTrial in peopleInterventionsPaper
ENDO 2025 Abstract·23 OctMON-691 Oral Delivery Of A Bispecific GLP-1/GLP-2 Receptor Agonist (PG-102) Via A Robotic Pill (RT-114) Achieves Bioequivalence To Subcutaneous Injection In CaninesExperiments in animalsInterventionsPaper